当前位置:首页 - 行情中心 - 赛诺医疗(688108) - 财务分析 - 现金流量表

赛诺医疗

(688108)

  

流通市值:55.63亿  总市值:55.63亿
流通股本:4.18亿   总股本:4.18亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金513,464,915.45342,960,089.73154,669,941.07575,128,400.61
  收到的税费返还2,507,118.871,137,381.82274,215.71162,496.89
  收到其他与经营活动有关的现金5,594,957.813,774,458.662,529,909.2523,623,843.72
  经营活动现金流入小计521,566,992.13347,871,930.21157,474,066.03598,914,741.22
  购买商品、接受劳务支付的现金76,319,411.3155,030,799.1126,290,569.5181,160,843.49
  支付给职工以及为职工支付的现金160,362,061.02110,959,111.0667,372,142.54197,769,912.37
  支付的各项税费46,094,336.3831,500,567.0913,899,120.653,311,310.54
  支付其他与经营活动有关的现金94,655,526.8956,226,582.7931,182,193.36104,798,326.79
  经营活动现金流出小计377,431,335.6253,717,060.05138,744,026.01437,040,393.19
  经营活动产生的现金流量净额144,135,656.5394,154,870.1618,730,040.02161,874,348.03
二、投资活动产生的现金流量:
  收回投资收到的现金130,000,00050,000,000--
  取得投资收益收到的现金325,888.8980,555.56--
  处置固定资产、无形资产和其他长期资产收回的现金净额25,60016,000-34,300.41
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计130,351,488.8950,096,555.56-34,300.41
  购建固定资产、无形资产和其他长期资产支付的现金14,823,978.1312,430,218.198,483,346.3545,800,047.72
  投资支付的现金130,000,00050,000,000--
  投资活动现金流出小计144,823,978.1362,430,218.198,483,346.3545,800,047.72
  投资活动产生的现金流量净额-14,472,489.24-12,333,662.63-8,483,346.35-45,765,747.31
三、筹资活动产生的现金流量:
  吸收投资收到的现金78,072,80078,072,80078,072,80013,534,400
  其中:子公司吸收少数股东投资收到的现金69,600,00069,600,000-2,000,000
  取得借款收到的现金123,440,000123,440,000105,440,00067,400,000
  收到其他与筹资活动有关的现金13,756,0006,919,9003,486,55032,914,150
  筹资活动现金流入小计215,268,800208,432,700186,999,350113,848,550
  偿还债务支付的现金98,700,00093,200,00093,200,00076,500,000
  分配股利、利润或偿付利息支付的现金2,190,460.881,475,114.18756,724.434,194,500.02
  支付其他与筹资活动有关的现金166,641,279.34160,621,434.89123,478,014.1742,896,072.78
  筹资活动现金流出小计267,531,740.22255,296,549.07217,434,738.6123,590,572.8
  筹资活动产生的现金流量净额-52,262,940.22-46,863,849.07-30,435,388.6-9,742,022.8
四、汇率变动对现金及现金等价物的影响-1,241,767.12-1,040,589.32-236,435.78-1,635,126.9
五、现金及现金等价物净增加额76,158,459.9533,916,769.14-20,425,130.71104,731,451.02
  加:期初现金及现金等价物余额396,406,143.96396,406,143.96396,406,143.96291,674,692.94
  期末现金及现金等价物余额472,564,603.91430,322,913.1375,981,013.25396,406,143.96
补充资料:
  净利润-55,576,065.16-47,465,942.71
  资产减值准备-5,997,143.8-3,912,065.46
  固定资产和投资性房地产折旧-11,231,231.82-24,620,748.51
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,231,231.82-24,620,748.51
  无形资产摊销-19,015,373.17-40,239,087.62
  长期待摊费用摊销-1,505,822.87-18,366,136.15
  处置固定资产、无形资产和其他长期资产的损失-1,590.71--
  固定资产报废损失-1,295.71-73,578.78
  财务费用-3,073,076.15-6,681,424.74
  投资损失--75,995.81--
  递延所得税-11,566,945.65-20,960,361.82
  其中:递延所得税资产减少-14,494,731.38-26,292,261.26
    递延所得税负债增加--2,927,785.73--5,331,899.44
  存货的减少--922,898.61-4,140,923.8
  经营性应收项目的减少-47,314.51--16,592,780.43
  经营性应付项目的增加--18,059,114.33-213,120.87
  其他---986,660
  现金的期末余额-430,322,913.1-396,406,143.96
  减:现金的期初余额-396,406,143.96-291,674,692.94
  现金及现金等价物的净增加额-33,916,769.14-104,731,451.02
公告日期2026-10-312026-08-272026-04-292026-03-26
审计意见(境内)标准无保留意见
TOP↑